Footrace to clinic heats up for T-cell nuclear receptor inhibitors.Published in:Nature Biotechnology, 2013, v. 31, n. 5, p. 370, doi. 10.1038/nbt0513-370By:Sheridan, CormacPublication type:Article
Newsmaker: Lycera.Published in:Nature Biotechnology, 2011, v. 29, n. 8, p. 679, doi. 10.1038/nbt0811-679By:Garber, KenPublication type:Article
New cellular bioenergetics approach to the treatment of autoimmune diseases.Published in:Expert Review of Clinical Immunology, 2011, v. 7, n. 2, p. 134Publication type:Article